Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

19

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

178087383

Full Text :

https://doi.org/10.1200/JCO.23.02329